Repligen Corp (RGEN) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $167.49 +1.08%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Repligen Corp (NASDAQ: RGEN) reported Q1 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $7.65 million versus the consensus estimate of $7.5 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
